{"id":"https://openalex.org/W7214905298","doi":"https://doi.org/10.3389/fimmu.2026.1979026","title":"Editorial: Advances in immunogenicity risk assessment, monitoring and mitigation of biologics","display_name":"Editorial: Advances in immunogenicity risk assessment, monitoring and mitigation of biologics","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214905298","doi":"https://doi.org/10.3389/fimmu.2026.1979026","pmid":"https://pubmed.ncbi.nlm.nih.gov/42877522","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13662639"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1979026","doi":"https://doi.org/10.3389/fimmu.2026.1979026","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1979026","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1979026/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1979026/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051006720","display_name":"Sophie Tourdot","orcid":"https://orcid.org/0000-0002-4912-1861","observed_orcids":["https://orcid.org/0000-0002-4912-1861"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophie Tourdot","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033709745","display_name":"Daniela I. Verthelyi","orcid":"https://orcid.org/0000-0002-5450-3071","observed_orcids":["https://orcid.org/0000-0002-5450-3071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Verthelyi","raw_affiliation_strings":["Thimmus, LLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thimmus, LLC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045188549","display_name":"Marc J. Pallardy","orcid":"https://orcid.org/0000-0001-8869-0365","observed_orcids":["https://orcid.org/0000-0001-8869-0365"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marc Pallardy","raw_affiliation_strings":["INSERM UMR 996, Universite Paris-Saclay"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM UMR 996, Universite Paris-Saclay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081850567","display_name":"Timothy Paul Hickling","orcid":"https://orcid.org/0000-0002-8918-2140","observed_orcids":["https://orcid.org/0000-0002-8918-2140"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Timothy Paul Hickling","raw_affiliation_strings":["Quasor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quasor","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5081850567"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1979026","last_page":"1979026"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.020800000056624413,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.781000018119812},{"id":"https://openalex.org/keywords/biologics","display_name":"biologics","score":0.828000009059906},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.9520000219345093},{"id":"https://openalex.org/keywords/risk-assessment","display_name":"risk assessment","score":0.43700000643730164},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.9290000200271606},{"id":"https://openalex.org/keywords/t-cell-priming","display_name":"T cell priming","score":0.7099999785423279},{"id":"https://openalex.org/keywords/sequence-modification","display_name":"sequence modification","score":0.39800000190734863},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9190000295639038},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8140000104904175},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.7559999823570251},{"id":"https://openalex.org/keywords/assay-comparability","display_name":"assay comparability","score":0.8299999833106995},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9909999966621399},{"id":"https://openalex.org/keywords/therapeutic-peptides","display_name":"peptide therapeutics","score":0.902999997138977},{"id":"https://openalex.org/keywords/new-approach-methodologies","display_name":"new approach methodologies","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8896999955177307},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5424000024795532},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.492900013923645},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.45649999380111694},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44429999589920044},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.4336000084877014},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3499000072479248},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3409999907016754},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.33629998564720154},{"id":"https://openalex.org/C124535831","wikidata":"https://www.wikidata.org/wiki/Q4915074","display_name":"Biomarker discovery","level":4,"score":0.335099995136261},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3346000015735626},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32409998774528503},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.30880001187324524},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3066999912261963},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30630001425743103},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.30300000309944153},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2879999876022339},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27810001373291016},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2727000117301941},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C66782513","wikidata":"https://www.wikidata.org/wiki/Q864601","display_name":"Biomedicine","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.26100000739097595},{"id":"https://openalex.org/C152662350","wikidata":"https://www.wikidata.org/wiki/Q815297","display_name":"Systems biology","level":2,"score":0.257099986076355},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2508000135421753}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1979026","doi":"https://doi.org/10.3389/fimmu.2026.1979026","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1979026","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1979026/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13662639","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13662639/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13662639/pdf/fimmu-17-1979026.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42877522","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42877522","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Editorial"},{"id":"pmh:oai:doaj.org/article:bc55cf955bc644d78bedc52cc9745da5","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/bc55cf955bc644d78bedc52cc9745da5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1979026","doi":"https://doi.org/10.3389/fimmu.2026.1979026","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1979026","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1979026/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214905298.pdf","grobid_xml":"https://content.openalex.org/works/W7214905298.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7155500481","https://openalex.org/W4210366603","https://openalex.org/W3042894437","https://openalex.org/W7128245423","https://openalex.org/W2003712657","https://openalex.org/W1114352","https://openalex.org/W2029859966","https://openalex.org/W2574621329","https://openalex.org/W3152173043","https://openalex.org/W4379093819"],"abstract_inverted_index":{"Early-stage":[0],"risk":[1,343,376,530,547],"prediction":[2],"is":[3,32,101,248,378,657,767,775],"paramount":[4],"to":[5,27,39,76,141,200,211,227,289,381,566,593,663,712,735,755,808,818],"designing":[6],"safer":[7],"biotherapeutics.":[8],"The":[9,454,690],"articles":[10,510],"in":[11,20,105,182,185,239,244,439,467,497,545,581,604,607,612,633,804],"this":[12,127,466,572,785],"section":[13],"highlight":[14],"how":[15,116,475],"computational":[16],"modeling":[17],"and":[18,84,184,297,319,328,367,391,451,557,597,606,619,636,660,683,706,722,739,753,793,801,813],"sophisticated":[19,603],"vitro":[21,186,608],"assays":[22,544],"are":[23,517],"refining":[24],"our":[25],"ability":[26],"predict":[28,713],"immunogenic":[29],"liabilities.":[30],"This":[31,73],"consistent":[33],"with":[34,415,481],"a":[35,53,102,112,136,146,165,208,267,283,309,331,399,490,523,549,577,594,650,771,776,790,794],"broader":[36],"industry":[37],"effort":[38],"generate":[40],"New":[41],"Approach":[42],"Methodologies":[43],"(NAMs)":[44],"for":[45,129,149,236,263,276,299,314,503,527,541,554,645,692,796],"translational":[46],"research.Model-Informed":[47],"Predictions:":[48],"Rose":[49],"et":[50,109,133,155,192,252,280,306,350,405,425,463,487,520,536],"al.":[51,110,134,156,193,253,281,307,351,406,426,464,488,521,537],"introduce":[52],"model-informed":[54],"metric":[55],"that":[56,158,385,408,428,563,648,757],"transitions":[57],"beyond":[58],"predicting":[59],"ADA":[60,287,716],"incidence":[61],"towards":[62],"evaluating":[63],"the":[64,78,170,179,202,217,233,255,258,317,335,356,361,382,429,444,468,493,512,560,582,586,613,629,640,655,664,666,688,693,742,748],"potential":[65,622],"impact":[66],"of":[67,181,204,257,337,364,373,402,433,446,456,470,495,552,559,584,702,779],"ADAs":[68,393,410],"on":[69,115,169,334,341,355,492,697],"therapeutic":[70,117,220,245,338],"PK":[71],"[1].":[72],"approach":[74,140,199],"contributes":[75],"bridging":[77],"gap":[79],"between":[80],"early":[81,150,611],"preclinical":[82],"predictions":[83],"clinical":[85,272,400,447,653,723],"outcome":[86],"modeling.Targeting":[87],"Early":[88],"Immune":[89],"Events:":[90,397],"Antigen":[91],"internalization":[92],"by":[93,120,745],"antigen-presenting":[94],"cells":[95,99,122,562],"(APCs),":[96],"particularly":[97],"dendritic":[98],"(DCs),":[100],"rate-limiting":[103],"step":[104,269],"T-cell":[106,437],"priming.":[107],"Lteif":[108],"provide":[111,330,538],"comprehensive":[113,332],"perspective":[114,333],"antibody":[118,321,472],"uptake":[119],"immune":[121,196,214,476,561],"dictates":[123],"immunogenicity":[124,176,203,229,336,375,455,494,529,567,591,667,766],"[2].":[125],"Implementing":[126],"science":[128],"drug":[130,246,318,651,781,802],"development,":[131],"Yin":[132],"present":[135],"high-throughput,":[137,284],"real-time":[138],"imaging":[139],"quantify":[142],"DC":[143],"internalization,":[144],"offering":[145],"robust":[147],"tool":[148],"screening":[151],"[3].Sequence-Level":[152],"Vulnerabilities:":[153],"Qin":[154],"demonstrated":[157,407],"even":[159],"minor":[160],"sequence":[161],"modifications,":[162],"such":[163,638,677],"as":[164,639,674,678,788],"single":[166],"point":[167],"mutation":[168],"FLT3L-Fc":[171],"protein,":[172],"can":[173,458,616],"significantly":[174,564],"elevate":[175],"risk,":[177],"underscoring":[178],"criticality":[180],"silico":[183,605],"de-risking":[187,609],"[4].Novel":[188],"Mitigation":[189],"Strategies:":[190],"Jarvi":[191],"explore":[194],"an":[195,353],"regulatory":[197,758,772],"adjuvant":[198],"mitigate":[201],"monoclonal":[205],"antibodies,":[206,266,680],"presenting":[207],"proactive":[209],"strategy":[210,313],"control":[212],"unwanted":[213],"responses":[215,438,448],"from":[216,394,511,588],"outset":[218],"[5].As":[219],"modalities":[221],"diversify,":[222],"bioanalytical":[223,737],"platforms":[224],"must":[225],"adapt":[226],"capture":[228],"profiles":[230],"accurately,":[231],"while":[232,485],"field":[234,583,694],"strives":[235],"industry-wide":[237],"harmonization.Standardization":[238],"Monitoring:":[240],"A":[241],"major":[242,507],"hurdle":[243],"monitoring":[247,273,656,738],"assay":[249,288],"comparability.":[250],"Wadhwa":[251],"detail":[254],"development":[256],"first":[259,641],"WHO":[260,642],"reference":[261,643],"panel":[262,644],"Infliximab":[264],"anti-drug":[265,320],"crucial":[268],"toward":[270],"harmonizing":[271],"[6].Platform":[274],"Innovations":[275],"Complex":[277],"Formats:":[278],"Fu":[279],"developed":[282],"Gyrolabbased":[285],"generic":[286],"support":[290],"antibody-drug":[291],"conjugate":[292],"(ADC)":[293],"evaluation,":[294],"optimizing":[295],"sensitivity":[296],"throughput":[298],"non-clinical":[300,546],"safety":[301,390,724],"studies":[302],"[7].":[303],"Similarly,":[304],"Valentine":[305],"propose":[308],"risk-driven,":[310],"1-tiered":[311],"testing":[312,322],"vidutolimod,":[315],"streamlining":[316],"process":[323],"[8].Addressing":[324],"Modality-Specific":[325],"Challenges:":[326],"Puig":[327],"Shubow":[329],"peptides,":[339],"focusing":[340],"product-related":[342],"factors":[344,727],"[9].":[345],"For":[346],"gene":[347,681],"therapies,":[348,473,682,686],"Chen":[349],"offer":[352,489],"opinion":[354],"AAV2-associated":[357],"liver":[358],"injury,":[359],"discussing":[360],"complex":[362,673,719],"interplay":[363],"viral":[365],"vectors":[366],"pre-existing":[368,731],"immunity":[369],"[10].The":[370],"ultimate":[371],"test":[372],"any":[374],"assessment":[377,531],"its":[379],"translation":[380],"clinic,":[383],"ensuring":[384],"findings":[386],"directly":[387],"inform":[388],"patient":[389],"management.Decoupling":[392],"Clinical":[395],"Adverse":[396],"In":[398],"evaluation":[401],"adalimumab,":[403],"Tourdot":[404,535],"treatment-emergent":[409],"do":[411],"not":[412,714],"necessarily":[413],"correlate":[414],"immunologically":[416],"related":[417],"adverse":[418],"events":[419],"[11].":[420],"Conversely,":[421],"van":[422],"de":[423],"Beek":[424],"show":[427],"TNF\u03b1":[430],"binding":[431],"domain":[432],"adalimumab":[434],"elicits":[435],"CD4+":[436],"rheumatoid":[440],"arthritis":[441],"patients,":[442],"highlighting":[443],"complexity":[445],"[12].Clinical":[449],"Context":[450],"Patient":[452],"Factors:":[453],"biotherapeutics":[457],"be":[459],"highly":[460],"context-dependent.":[461],"Irvine":[462],"discuss":[465],"case":[469],"anti-SARS-CoV-2":[471],"showing":[474],"complexes":[477],"form":[478],"during":[479],"co-administration":[480],"mRNA":[482],"vaccines":[483],"[13],":[484],"Tsai":[486],"commentary":[491],"dupilumab":[496],"adult":[498],"versus":[499],"pediatric":[500],"patients":[501,819],"[14].Consensus":[502],"Tailored":[504],"Mitigation:":[505],"Representing":[506],"milestones,":[508],"two":[509],"European":[513,749],"Immunogenicity":[514,750],"Platform":[515,751],"(EIP)":[516,752],"featured.":[518],"Grudzinska-Goebel":[519],"deliver":[522,809],"harmonized,":[524],"practical":[525],"framework":[526],"overall":[528],"[15].":[532],"Complementing":[533],"this,":[534],"best":[539],"practices":[540],"T":[542],"cell":[543,685],"assessment,":[548],"critical":[550],"set":[551],"NAMs":[553],"mechanistic":[555],"understanding":[556],"translatability":[558],"contribute":[565],"[16].The":[568],"16":[569],"contributions":[570],"encompassing":[571],"Research":[573],"Topic":[574],"collectively":[575],"demonstrate":[576],"pivotal":[578],"paradigm":[579],"shift":[580],"biotherapeutics:":[585],"transition":[587],"reactive,":[589],"post-hoc":[590],"management":[592],"proactive,":[595],"predictive,":[596],"structurally":[598],"harmonized":[599],"approach.":[600],"By":[601],"integrating":[602],"models":[610],"pipeline,":[614],"developers":[615,803],"now":[617],"identify":[618],"engineer":[620],"out":[621],"molecular":[623],"vulnerabilities":[624],"before":[625],"they":[626],"ever":[627],"reach":[628],"clinic.":[630],"Furthermore,":[631],"advancements":[632],"high-throughput":[634],"bioanalytics":[635],"standardization,":[637],"infliximab,":[646],"ensure":[647,756],"once":[649],"enters":[652],"trials,":[654],"robust,":[658],"reproducible,":[659],"clinically":[661],"meaningful.Looking":[662],"future,":[665],"landscape":[668],"will":[669],"only":[670],"grow":[671],"more":[672,811,814],"novel":[675],"modalities,":[676],"multi-specific":[679],"engineered":[684],"enter":[687],"mainstream.":[689],"outlook":[691],"relies":[695],"heavily":[696],"three":[698],"key":[699],"frontiers:1.":[700],"Integration":[701],"Artificial":[703],"Intelligence":[704],"(AI)":[705],"Machine":[707],"Learning:":[708],"Expanding":[709],"modelinformed":[710],"metrics":[711],"just":[715,770],"incidence,":[717],"but":[718],"PK/PD":[720],"impacts":[721],"outcomes.Leveraging":[725],"patient-specific":[726],"(e.g.,":[728],"HLA":[729],"typing,":[730],"immunity,":[732],"disease":[733],"state)":[734],"tailor":[736],"tolerance-inducing":[740],"regimens.Continuing":[741],"momentum":[743],"built":[744],"consortia":[746],"like":[747],"AAPS":[754],"frameworks":[759],"globally":[760],"adopt":[761],"unified,":[762],"risk-based":[763],"strategies.Ultimately,":[764],"mitigating":[765],"no":[768],"longer":[769],"checkbox;":[773],"it":[774],"fundamental":[777],"pillar":[778],"rational":[780],"design.":[782],"We":[783],"hope":[784],"collection":[786],"serves":[787],"both":[789],"foundational":[791],"resource":[792],"catalyst":[795],"future":[797],"innovations,":[798],"guiding":[799],"researchers":[800],"their":[805],"shared":[806],"mission":[807],"safer,":[810],"efficacious,":[812],"accessible":[815],"life-changing":[816],"biologics":[817],"worldwide.":[820]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-01T00:00:00"}